Precision BioSciences, Inc.
DTIL
$6.30
$0.6311.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.13M | -21.77M | -23.52M | -20.57M | -17.75M |
| Total Depreciation and Amortization | 678.00K | 674.00K | 696.00K | 705.00K | 757.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.85M | 3.94M | 5.17M | 2.10M | -2.60M |
| Change in Net Operating Assets | -27.21M | 1.89M | -2.62M | -1.30M | 901.00K |
| Cash from Operations | -11.25M | -15.27M | -20.27M | -19.05M | -18.68M |
| Capital Expenditure | -19.00K | 0.00 | -2.00K | -64.00K | -97.00K |
| Sale of Property, Plant, and Equipment | 44.00K | 17.00K | 5.00K | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -350.00K | 0.00 | -15.00K | -250.00K | 0.00 |
| Cash from Investing | -325.00K | 17.00K | -12.00K | -314.00K | -97.00K |
| Total Debt Issued | -- | -- | -- | -- | -20.00K |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 77.52M | 1.66M | 5.30M | 10.69M | 5.94M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 77.52M | 1.66M | 5.30M | 10.69M | 5.92M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.94M | -13.59M | -14.98M | -8.68M | -12.86M |